Measles, Money and Pennsylvania’s Vaccine War Room

1. Measles, Money and Pennsylvania’s Vaccine War Room
2. Who Benefits From Pennsylvania’s Vaccine Policy?
3. Pennsylvania Vaccines: Follow the Money

Meta Description

A closer look at Pennsylvania vaccine funding, measles deaths, state policy, and the political groups surrounding the 2026 Lancaster controversy.

Follow the Money

A recent report raises a simple question: Who benefits from Pennsylvania’s vaccine policies?

The report focuses on Governor Josh Shapiro, pharmaceutical investments, two reported measles-associated deaths, and the political organization Protect Our Care.

The timing is what caught my attention.

On June 26, 2026, Shapiro announced a $10.6 million Pennsylvania grant to Sanofi Pasteur at its Swiftwater facility. According to the source, the plant produces a large share of U.S. influenza vaccine.

About two months later, on August 25, Shapiro appeared in Lancaster County to discuss two measles-associated deaths.

The report argues that the financial relationship with the vaccine industry deserved to be disclosed when the Governor discussed vaccine policy.

That is a question worth examining.

DISCLAIMER: The information in this article is not meant to treat, cure or diagnose. Always consult with your healthcare provider before adding a new protocol. This is purely for your entertainment.

I use a few methods to teach my friends and family how to beat terminal cancer,  etc. ALS, Parkinsons, autism, arthritis, macular degeneration, MS, Fibromyalgia, because my friend Peter January 2025 was told he had 3 months to live. I put him on the cancer protocol and in 9 months he shocked the chemo docs when he was NED, no evidence of disease.

HERE IS THE LINK TO BUY BUT CALL ME FIRST to be educated

Pennsylvania’s Vaccine Industry

The source lists billions of dollars in pharmaceutical and life-science investments connected to Pennsylvania.

It highlights GSK in Marietta, where the state supported an $800 million expansion. The state has described the facility as producing vaccines and medicines.

The report also points to Eli Lilly, Johnson & Johnson, Eurofins, and Sanofi.

One statement receives particular attention.

Pennsylvania Executive Order 2025-02 says the Commonwealth manufactures more than one-half of all vaccines administered in the United States.

The order also calls for Pennsylvania to use its leadership in vaccine research, development, and manufacturing.

That does not automatically prove wrongdoing. It does show that vaccines are a major part of Pennsylvania’s economic and public-health infrastructure.

What Happened in Lancaster?

The source says Pennsylvania announced two measles-associated deaths on August 25.

It questions why additional medical information was not immediately released.

The report says the public did not receive complete details about the clinical courses, immediate causes of death, laboratory testing, sequencing, or vaccination-status verification.

There is also an important distinction between “measles-associated” and “death caused by measles.”

Those terms should not automatically be treated as identical.

The report cites statements attributed to the Lancaster County coroner concerning one infant who reportedly had measles antibodies but died after a serious medical event involving a ruptured spleen.

Because these are serious medical claims, the underlying medical records matter more than political statements from either side.

Enter Protect Our Care

The report also examines Protect Our Care, a Washington-based advocacy organization.

According to the source, the organization has longstanding connections with Democratic political and public-health campaigns.

It identifies founder Leslie Dach and president Brad Woodhouse, along with staff members involved in public-health messaging.

The report argues that Protect Our Care had already been running an anti-RFK Jr. campaign before the Lancaster announcement.

It also points to polling conducted shortly before the measles announcement.

The important question is not simply whether an advocacy organization has a political viewpoint. Political organizations are allowed to advocate.

The question is whether the public can clearly see who is funding the message, who is producing it, and who benefits from it.

Transparency Matters

This story involves politics, vaccines, public money, and grieving families.

That combination requires careful reporting.

The strongest part of the story is the call for transparency.

The public deserves accurate information about public grants, pharmaceutical investments, political advocacy groups, and the medical facts surrounding reported deaths.

At the same time, allegations of corruption or a “pay-to-play” arrangement require evidence beyond timing or association.

That distinction is important.

My goal is to follow the documents, ask questions, and let readers examine the evidence for themselves.

For more of my health and independent research, visit Amalya at GrowthFactor on Substack.

You can also visit AmalyaOppenheimer.com for more information and articles.

The Bigger Question

Who pays?

Who receives?

Who makes the policy?

Who creates the public message?

And who is responsible for telling the public when there may be a financial or political connection?

Those questions should be asked about everyone—government officials, pharmaceutical companies, advocacy organizations, political campaigns, and the media.

The answer should come from documents and evidence, not slogans.

That is why the Pennsylvania story deserves a closer look.